Welcome to CRWENewswire, Stocks to watch. I am Shalika Jayasekera. Idera Pharmaceuticals Incorporated - symbol IDRA - reported that it has raised $9.5 million in a convertible preferred stock offering. Idera intends to use the net proceeds from the transaction for general corporate purposes, including continuing to fund development of its Toll-like Receptor targeted candidates, being developed to treat autoimmune and inflammatory diseases, cancer, and for use as vaccine adjuvants, and its gene-silencing oligonucleotide technology. More information about Idera Pharmaceuticals Incorporated - symbol IDRA - at iderapharma.com. Thanks for joining me and have a great day! For CRWE Newswire, Stocks to watch, I’m Shalika Jayasekera